Impact of smoking status on the biological behavior of lung cancer
- PMID: 17713724
- DOI: 10.1007/s00595-007-3516-6
Impact of smoking status on the biological behavior of lung cancer
Abstract
Cigarette smoking is the most established risk factor for lung carcinogenesis; however, its effects on the progression of lung cancer are still unclear. We reviewed the clinical investigations on this issue, which imply that smoking status is a treatment predictor and prognostic factor for several subtypes of lung cancer. Moreover, gene alterations and various protein expressions of tumor progression were recognized more frequently in the tumor tissues of smokers than in those of the never smokers. A cellular analysis revealed that tobacco-specific chemical compounds cause genetic or epigenetic alterations, modulate expressions of large numbers of genes that include molecules related to proliferation, invasion and metastasis, and deteriorate anti-tumor immunity. Our findings suggest that smoking promotes the progression of lung cancer, and that elucidating the molecular mechanisms may help to clarify the therapeutic targets.
Similar articles
-
Association between cigarette smoking and FHIT gene alterations in lung cancer.Cancer Res. 1997 Jun 1;57(11):2121-3. Cancer Res. 1997. PMID: 9187107
-
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers.Hum Mol Genet. 2017 Aug 1;26(15):3014-3027. doi: 10.1093/hmg/ddx188. Hum Mol Genet. 2017. PMID: 28854564 Free PMC article.
-
Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.Carcinogenesis. 2004 Nov;25(11):2165-71. doi: 10.1093/carcin/bgh217. Epub 2004 Jul 1. Carcinogenesis. 2004. PMID: 15231689
-
Lung cancer epigenetics and genetics.Int J Cancer. 2008 Jul 1;123(1):1-7. doi: 10.1002/ijc.23605. Int J Cancer. 2008. PMID: 18425819 Review.
-
Tobacco, inflammation, and respiratory tract cancer.Curr Pharm Des. 2012;18(26):3901-38. doi: 10.2174/138161212802083743. Curr Pharm Des. 2012. PMID: 22632749 Review.
Cited by
-
Superior vena cava reconstruction via a posterolateral thoracotomy without venous occlusion for locally advanced lung cancer: report of a case.Surg Today. 2009;39(9):787-9. doi: 10.1007/s00595-008-3927-z. Epub 2009 Sep 24. Surg Today. 2009. PMID: 19779775
-
Associations Between CAMKK1 Polymorphism rs7214723 and the Prognosis of Patients With Lung Cancer.Front Oncol. 2021 Nov 19;11:757484. doi: 10.3389/fonc.2021.757484. eCollection 2021. Front Oncol. 2021. PMID: 34868969 Free PMC article.
-
α7 nicotinic acetylcholine receptors in lung cancer.Oncol Lett. 2018 Aug;16(2):1375-1382. doi: 10.3892/ol.2018.8841. Epub 2018 May 30. Oncol Lett. 2018. PMID: 30008813 Free PMC article. Review.
-
Prognostic value of a novel scoring system using inflammatory response biomarkers in non-small cell lung cancer: A retrospective study.Thorac Cancer. 2019 Jun;10(6):1402-1411. doi: 10.1111/1759-7714.13085. Epub 2019 May 18. Thorac Cancer. 2019. PMID: 31104359 Free PMC article.
-
Prognostic Significance of CONUT Score in Elderly NSCLC.Ann Thorac Cardiovasc Surg. 2024;30(1):24-00009. doi: 10.5761/atcs.oa.24-00009. Ann Thorac Cardiovasc Surg. 2024. PMID: 38569836 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical